Investing

Top Analyst Upgrades and Downgrades: Albermarle, Biogen, Fisker, GM, Livent, Marriott, Uber, Yelp and More

monsitj / Getty Images

Stock futures were indicated to open more than 1% higher after Joe Biden was being declared the winner of the presidential race, but equity futures then exploded higher at 6:45 a.m. after the Pfizer/BioNTech COVID-19 treatment was announced to have over 90% efficacy against the coronavirus. Many of the recovery and reopen stocks were the leaders on Monday, and some of the work-from-home and stay-at-home stocks traded lower. Investors are trying to consider new ideas about how to be positioned heading into 2021, even with many unknowns still ahead.

24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy. Other calls cover stocks to sell or avoid. Remember that no single analyst call should ever be used as a basis to buy or sell a stock. Consensus analyst target data is from Refinitiv.

These are the top analyst upgrades, downgrades and initiations seen on Monday, November 9, 2020.

Albemarle Corp. (NYSE: ALB) was raised to Buy from Neutral with a $132 price target at Citigroup. The stock was up over 6% at $112.22 on Friday, and its shares were trading up almost 3% at $115.00 on Monday.

Analog Devices Inc. (NASDAQ: ADI) was upgraded to Outperform from In-Line and its target was raised to $160 from $135 at Evercore ISI Group. The stock was indicated up almost 2% at $136.00 a share on Monday, and it has a $138.16 consensus target price.

Array Technologies Inc. (NASDAQ: ARRY) was up 13.9% at $44.81 per share, but it traded down nearly 3% at $43.50 on Monday after the analysts were free to start coverage. The shares were started as Equal Weight at Barclays, as Neutral at JPMorgan, as Neutral at Credit Suisse, as Market Perform at Cowen and as Underweight at Morgan Stanley.

Biogen Inc. (NASDAQ: BIIB) had seen its shares surge on what was expected to be a favorable FDA panel nod for its Alzheimer’s drug, but the advisory committee gave a recommendation against approving the drug. The shares were all the way back down 28% at $236.00 on Monday morning. BofA Securities downgraded it to Underperform from Neutral, Cowen it downgraded to Market Perform from Outperform, and Atlantic Equities downgraded it to Underweight from Neutral.

Cheesecake Factory Inc. (NASDAQ: CAKE) was raised to Buy from Hold with a $40 price target at Deutsche Bank.

Delta Air Lines Co. (NYSE: DAL) was named as the Zacks Bear of the Day stock. The firm said that it is still tough to be an airline and the road to recovery will be tough as well. Shares last closed at $31.42 and have a consensus price target of $38.78.

Fisker Inc. (NYSE: FSR) was started as Outperform with a $22 price target at Cowen. The stock closed down 1.3% at $10.86 per share on Friday, but it was indicated up 7% at $11.63 on Monday.


General Motors Co. (NYSE: GM) was reiterated as Overweight at Morgan Stanley, but the firm did trim its price target to $44 from $46. Shares of GM closed up 0.9% at $37.47 per share on Friday, and the stock was indicated up 3.5% at $38.75 on Monday.

Livent Corp. (NYSE: LTHM) was raised to Buy from Neutral with a $16.50 price target at Citigroup. Livent was up over 15% at $13.65 on Friday and was indicated up another 7.2% at $14.60 on Monday.

Marriott International Inc. (NYSE: MAR) was reiterated as Hold but its target was raised to $99 from $94 (versus a $103.89 prior close) at Truist Securities. Morgan Stanley maintained its Equal Weight rating but raised its price target to $100 from $93.

Mattel Inc. (NASDAQ: MAT) was downgraded to Hold from Buy at Jefferies.

Royalty Pharma PLC (NASDAQ: RPRX) was raised to Buy from Neutral with a $51 target price (versus a $40.24 prior close) at UBS. The stock was indicated up over 4% at $42.00 a share on Monday, and it had a $52.29 consensus price target.

Tapestry Inc. (NYSE: TPR) was named as the Bull of the Day at Zacks, which said this retailer has staged a huge recovery amid the coronavirus pandemic. Shares most recently closed at $24.32 and have a consensus price target of $26.71.

TripAdvisor Inc. (NASDAQ: TRIP) closed down 2.7% at $19.98 a share on Friday, but the news of the COVID-19 impact on travel stocks had it up 21% at $24.25 on Monday. Needham maintained its Buy rating but lowered its price target to $25 from $26.

Uber Technologies Inc. (NYSE: UBER) was reiterated as Outperform and its price target was raised to $58 from $42 at JMP Securities. The shares were indicated up 8.5% at $48.70 on Monday due to the reopening stocks gaining after news of the Pfizer/BioNTech vaccine.

Vista Outdoor Inc. (NYSE: VSTA) was raised to Overweight from Sector Weight with a $30 target price at KeyBanc Capital Markets. The stock closed up 6.5% at $23.50 a share on Friday and was indicated up another 3.3% at $24.25 on Monday. It had a $30.33 consensus target price ahead of the call.

Yelp Inc. (NYSE: YELP) was raised to Neutral from Sell with a $26 target price at UBS. The stock closed up 8.7% at $23.94 on Friday, and it was indicated up another 10% at $26.50 per share on Monday.


With technology momentum plays continuing to rip higher, some investors looking to stay in the sector are shifting capital to dividend-paying tech leaders. Five are rated Buy at BofA Securities and have a bigger dividend than the S&P 500.

Friday’s top analyst upgrades and downgrades included Advanced Micro Devices, BigCommerce, Electronic Arts, New Relic, SAP, T-Mobile, Uber Technologies, Yelp and Zillow.

Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)

Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.

Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.

Click here now to get started.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.